Cleopatra Hospitals Group results, Q3 2024
Net profit, assets, equity and cash flow for Q3 2024, against the same period a year earlier, from the published financial statements.
Net profit207 millionEGP · +73.1% vs the same period a year earlier
Total assets6.84 billionEGP · +71.4% vs the same period a year earlier
Shareholders' equity2.95 billionEGP · +27.2% vs the same period a year earlier
Operating cash flow817 millionEGP · +242.7% vs the same period a year earlier
In short
- Cleopatra Hospitals Group's net profit for Q3 2024 was about 207 million EGP, up +73.1% from 120 million EGP in Q3 2023.
- Total assets at the end of Q3 2024 were about 6.84 billion EGP, and shareholders' equity about 2.95 billion EGP.
- Operating cash flow for Q3 2024 was positive at 817 million EGP.
Key lines against the same period a year earlier
This periodQ3 2023Change
Net profit207 million120 million+73.1%
Gross profit591 million358 million+64.9%
Total assets6.84 billion3.99 billion+71.4%
Total liabilities3.9 billion1.68 billion+132.4%
Shareholders' equity2.95 billion2.32 billion+27.2%
Total liabilities and equity6.84 billion3.99 billion+71.4%
Operating cash flow817 million238 million+242.7%
Investing cash flow-1.1 billion-197 million−456.9%
Financing cash flow431 million-10.24 million+4303.9%
Net change in cash149 million30.83 million+382.5%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Cleopatra Hospitals Group's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy